San Francisco, CA · Founded 2023 · Privately Held (backing)
Operator of a clinical-stage, next-generation gene correction company intended to cure serious and life-threatening diseases. Kamau Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $48.5 million at its seed round in Jun 2025, the last priced event on record. It has raised $31.8 million across 1 recorded round; the latest was a $5 million seed round in May 2025.
PMV mark · valuation
$48.5M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$31.8M
Last round
Seed Round
May 2025
Team — not yet on record
No current team members for Kamau Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kamau Therapeutics with a free account
·Watch Kamau Therapeutics: the Monday email on marks, rounds and moves
